Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Aeglea Biotherapeutics Inc (AGLE)
NASDAQ:AGLE
RESEARCH TOOLSreports
Holding AGLE?
Track your performance easily
AGLE Stock Chart & Stats
Day’s Range$10.69 - $12.34
52-Week Range― - ―
Previous Close$11.04
Volume43.37K
Average Volume (3M)N/A
Market Cap
$44.70M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next Earnings
Mar 13, 2024EPS Estimate
-$0.91Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$17.50Price Target Upside45.71% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Aeglea Biotherapeutics News
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
66.86% Other Institutional Investors
33.14% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AGLE FAQ
What was Aeglea Biotherapeutics Inc’s price range in the past 12 months?
Currently, no data Available
What is Aeglea Biotherapeutics Inc’s market cap?
Currently, no data Available
When is Aeglea Biotherapeutics Inc’s upcoming earnings report date?
Aeglea Biotherapeutics Inc’s upcoming earnings report date is Mar 13, 2024 which is 242 days ago.
How were Aeglea Biotherapeutics Inc’s earnings last quarter?
Aeglea Biotherapeutics Inc released its earnings results on Nov 09, 2023. The company reported -$9.34 earnings per share for the quarter, missing the consensus estimate of -$0.6 by -$8.74.
Is Aeglea Biotherapeutics Inc overvalued?
According to Wall Street analysts Aeglea Biotherapeutics Inc’s price is currently Undervalued.
Does Aeglea Biotherapeutics Inc pay dividends?
Aeglea Biotherapeutics Inc does not currently pay dividends.
What is Aeglea Biotherapeutics Inc’s EPS estimate?
Aeglea Biotherapeutics Inc’s EPS estimate is -$0.91.
How many shares outstanding does Aeglea Biotherapeutics Inc have?
Currently, no data Available
What happened to Aeglea Biotherapeutics Inc’s price movement after its last earnings report?
Aeglea Biotherapeutics Inc reported an EPS of -$9.34 in its last earnings report, missing expectations of -$0.6. Following the earnings report the stock price went up 0.211%.
Which hedge fund is a major shareholder of Aeglea Biotherapeutics Inc?
Among the largest hedge funds holding Aeglea Biotherapeutics Inc’s share is Driehaus Capital Management LLC. It holds Aeglea Biotherapeutics Inc’s shares valued at 10M.
---
Aeglea Biotherapeutics Stock Smart Score
Company Description
Aeglea Biotherapeutics Inc
Aeglea Biotherapeutics, Inc. operates as a clinical-stage biotechnology company, which develops next-generation human enzyme therapeutics as disruptive solutions for rare and other high-burden diseases. Its product pegzilarginase, is in a Phase 3 pivotal trial for the treatment of Arginase 1 Deficiency. The company was founded by George Georgiou and David G. Lowe in December 2013 and is headquartered in Austin, TX.
---
AGLE Stock 12 Month Forecast
Average Price Target
$17.50
▲(45.71% Upside)
Technical Analysis
Best Analysts Covering AGLE
1 Year
1 Year Success Rate
3/3 ratings generated profit
1 Year Average Return
+15.53%
reiterated a buy rating a year ago
Copying Alex Thompson CFA's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +15.53% per trade.
---